300896 Stock Overview
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Imeik Technology Development Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥160.62 |
| 52 Week High | CN¥352.42 |
| 52 Week Low | CN¥157.22 |
| Beta | 1.11 |
| 11 Month Change | -19.91% |
| 3 Month Change | -29.74% |
| 1 Year Change | -50.55% |
| 33 Year Change | -69.50% |
| 5 Year Change | n/a |
| Change since IPO | 19.01% |
Recent News & Updates
Shareholder Returns
| 300896 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -6.7% | -0.7% | -1.4% |
| 1Y | -50.6% | -22.5% | -18.4% |
Return vs Industry: 300896 underperformed the CN Biotechs industry which returned -22.5% over the past year.
Return vs Market: 300896 underperformed the CN Market which returned -18.4% over the past year.
Price Volatility
| 300896 volatility | |
|---|---|
| 300896 Average Weekly Movement | 5.0% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300896's share price has been volatile over the past 3 months.
Volatility Over Time: 300896's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 910 | Yifeng Shi | www.imeik.net/cn/ |
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel.
Imeik Technology Development Co.,Ltd. Fundamentals Summary
| 300896 fundamental statistics | |
|---|---|
| Market cap | CN¥48.32b |
| Earnings (TTM) | CN¥1.97b |
| Revenue (TTM) | CN¥3.05b |
24.5x
P/E Ratio15.9x
P/S RatioIs 300896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300896 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.05b |
| Cost of Revenue | CN¥155.17m |
| Gross Profit | CN¥2.89b |
| Other Expenses | CN¥920.29m |
| Earnings | CN¥1.97b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 22, 2024
| Earnings per share (EPS) | 6.56 |
| Gross Margin | 94.91% |
| Net Profit Margin | 64.71% |
| Debt/Equity Ratio | 0% |
How did 300896 perform over the long term?
See historical performance and comparison